Biosynex - Asset Resilience Ratio

Latest as of June 2025: 3.35%

Biosynex (ALBIO) has an Asset Resilience Ratio of 3.35% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Biosynex (ALBIO) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets

€5.00 Million

≈ $5.85 Million USD Cash + Short-term Investments

Total Assets

€149.44 Million

≈ $174.71 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2011–2024)

This chart shows how Biosynex's Asset Resilience Ratio has changed over time. See Biosynex net assets for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Biosynex's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see how much is Biosynex worth.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	€0.00	0%
Short-term Investments	€5.00 Million	3.35%
Total Liquid Assets	€5.00 Million	3.35%

Asset Resilience Insights

Limited Liquidity: Biosynex maintains only 3.35% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Biosynex Industry Peers by Asset Resilience Ratio

Compare Biosynex's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Vitrolife AB ST:VITR	Medical Devices	7.27%
Medprin Regenerative Medical Technologies Co. Ltd. SHE:301033	Medical Devices	19.31%
Tellgen Corp SHE:300642	Medical Devices	8.60%
Lumos Diagnostics Holdings Ltd AU:LDX	Medical Devices	9.40%
T&R Biofab Co. Ltd KQ:246710	Medical Devices	0.12%
Ok Biotech Co Ltd TW:4155	Medical Devices	0.32%
Promimic AB ST:PRO	Medical Devices	8.62%
Memphasys Ltd AU:MEM	Medical Devices	0.00%

Annual Asset Resilience Ratio for Biosynex (2011–2024)

The table below shows the annual Asset Resilience Ratio data for Biosynex.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	2.57%	€5.00 Million ≈ $5.85 Million	€194.69 Million ≈ $227.61 Million	+0.09pp
2023-12-31	2.48%	€6.00 Million ≈ $7.01 Million	€241.73 Million ≈ $282.61 Million	+2.48pp
2022-12-31	0.00%	€1.00 ≈ $1.17	€259.98 Million ≈ $303.94 Million	-0.90pp
2021-12-31	0.90%	€2.42 Million ≈ $2.83 Million	€268.94 Million ≈ $314.42 Million	-3.21pp
2020-12-31	4.11%	€5.18 Million ≈ $6.06 Million	€126.07 Million ≈ $147.39 Million	+1.54pp
2019-12-31	2.57%	€1.22 Million ≈ $1.42 Million	€47.34 Million ≈ $55.35 Million	+1.92pp
2018-12-31	0.65%	€257.50K ≈ $301.04K	€39.46 Million ≈ $46.14 Million	-4.33pp
2017-12-31	4.98%	€2.02 Million ≈ $2.36 Million	€40.51 Million ≈ $47.36 Million	+3.46pp
2016-12-31	1.52%	€599.22K ≈ $700.55K	€39.51 Million ≈ $46.19 Million	-23.11pp
2013-12-31	24.63%	€1.80 Million ≈ $2.10 Million	€7.31 Million ≈ $8.55 Million	-10.98pp
2012-12-31	35.61%	€3.15 Million ≈ $3.68 Million	€8.85 Million ≈ $10.34 Million	-35.56pp
2011-12-31	71.16%	€4.33 Million ≈ $5.06 Million	€6.09 Million ≈ $7.12 Million	--

pp = percentage points

About Biosynex

PA:ALBIO France Medical Devices

Market Cap

$16.81 Million

€14.38 Million EUR

Market Cap Rank

#25694 Global

#426 in France

Share Price

€0.78

Change (1 day)

-2.50%

52-Week Range

€0.48 - €1.51

All Time High

€25.28